Chester County News and Community Website
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) announced it has received U.S. Food and Drug Administration (FDA) approval of a Suitability Petition allowing the company to proceed with its …
NRx Wins FDA Nod to Advance Preservative-Free Ketamine Product KETAFREE Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW; OTC: ONFOP) announced its Board of Directors has declared a regular quarterly dividend of $0.75 per share on the company’s outstanding …
Onfolio Declares Quarterly Dividend on Series A Preferred Stock Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) cream 1.5% for children as young as two with mild to moderate …
FDA Expands Approval of Incyte’s Opzelura to Treat Pediatric Atopic Dermatitis Read More
WILMINGTON, DE — The U.S. prescribing information for AIRSUPRA now includes results from the Phase IIIb BATURA trial, which demonstrated that the medication significantly reduced severe asthma exacerbations in patients …
AIRSUPRA Label Expanded With Evidence of Risk Reduction in Mild Asthma Read More
WILMINGTON, DE — EnterpriseDB (EDB) released new global research showing that most enterprises are struggling to scale agentic and generative AI, with 87% at risk of falling behind due to …
EnterpriseDB Report Warns 87% of Enterprises Risk Falling Behind in AI Race Read More
WILMINGTON, DE — Progresso Technology has introduced Guardely, a mobile-first safety app designed to provide real-time, location-based alerts that go beyond traditional crime data. With its new Danger Zone Alerts, …
Guardely Launches Real-Time Danger Zone Alerts to Redefine Personal Safety Read More WILMINGTON, DE — AstraZeneca announced positive interim results from its Phase III TULIP-SC trial showing that subcutaneous administration of SAPHNELO (anifrolumab) significantly reduced disease activity in patients with systemic lupus …
AstraZeneca Reports Positive Phase III Data for Subcutaneous Lupus Therapy Read More
WILMINGTON, DE — Intel 471 announced it has partnered with the Department of Defense’s SkillBridge program, opening its global cybersecurity business to service members transitioning from military to civilian careers.
Intel 471 Joins DOD SkillBridge to Support Transitioning Service Members Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) released new 24-week interim data from its pivotal Phase 3 STOP-HS trials, showing that its oral JAK1 inhibitor povorcitinib (INCB54707) delivered sustained efficacy and …
Incyte Reports Positive 24-Week Data for Povorcitinib in Hidradenitis Suppurativa Read More
WILMINGTON, DE — Second Front Systems (2F) announced it has received a Defense Information Systems Agency Provisional Authorization (DISA PA), placing the company among just 57 organizations with this designation, …
Second Front Systems Earns Key Defense Authorization for Game Warden Platform Read More